Search Results - Rowan E. Miller

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    The role of PARP inhibitor combination therapy in ovarian cancer by Helen Hockings, Rowan E. Miller

    Published in Therapeutic Advances in Medical Oncology (2023-05-01)
    Get full text
    Article


  2. 2

    Disparity in the era of personalized medicine for epithelial ovarian cancer by Michael-John Devlin, Rowan E. Miller

    Published in Therapeutic Advances in Medical Oncology (2023-01-01)
    Get full text
    Article


  3. 3

    Lung carcinoma with hypertrophic osteoarthropathy in a teenager by Jeremy Whelan, Rowland O. Illing, Rowan E. Miller

    Published in Rare Tumors (2011-03-01)
    Get full text
    Article


  4. 4

    Controversies and clinical unknowns in the use of PARP inhibitors in ovarian cancer by Uma A. Mukherjee, Rowan E. Miller, Jonathan A. Ledermann

    Published in Therapeutic Advances in Medical Oncology (2025-06-01)
    Get full text
    Article


  5. 5

    Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy by Georgina E. Wood, Christopher P. Bunting, Mesel Veli, Rupali Arora, Daniel M. Berney, Constantine Alifrangis, Nicola D. MacDonald, Rowan E. Miller, Rowan E. Miller, Jonathan Shamash, Sara Stoneham, Michelle Lockley, Michelle Lockley

    Published in Frontiers in Oncology (2023-10-01)
    Get full text
    Article


  6. 6

    First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors by Rebecca Kristeleit, Juan Martin-Liberal, Kristen Spencer, Janice M Mehnert, Maria Vieito, Elizabeth J Davis, Angela Orcurto, Thomas Condamine, Daniel C Cho, Jennifer Pulini, Rowan E Miller, Sarah P Blagden, Dominik Berthold, Dana B Cardin, Prashanth Hari Dass, John E Janik, Jason Clark, Xuejun Chen

    Published in Journal for ImmunoTherapy of Cancer (2022-10-01)
    Get full text
    Article


Search Tools: